Warning letterFDA · Feb 4, 2025
ISOThrive, Inc. MARCS-CMS 688547, February 04, 2025
Named company: ISOThrive, Inc.
ISOThrive’s failure to submit, and to have in effect, an IND before initiating clinical investigations with an investigational drug raises significant concerns regarding the safety and welfare of enrolled…
Lot information: not specified in this record.